Paul Tudor Jones Warns This “Disastrous Market Mania” Will End “By Revolution, Taxes, Or War”

“This gap between the 1% and the rest of America, and between the US and the rest of the world, cannot and will not persist,” warns renowned trader Paul Tudor Jones during his recent TED Talks speech, as he addressed the question – can capital be just? Hoping to expand the “narrow definitions of capitalism,” that threaten the underpinnings of society, Tudor Jones exclaims, “we’re in the middle of a disastrous market mania,” adding “one of worst of my life.” Perhaps most ominously, he concludes, historically this ends “by revolution, higher taxes or wars. None are on my bucket list.”
As TED blog reports,

Can capital be just? As a firm believer in capitalism and the free market, Paul Tudor Jones II believes that it can be. Tudor is the founder of the Tudor Investment Corporation and the Tudor Group, which trade in the fixed-income, equity, currency and commodity markets. He thinks it is time to expand the “narrow definitions of capitalism” that threaten the underpinnings of our society and develop a new model for corporate profit that includes justness and responsibility.

READ MORE
Please share this article

Celgene Corporation CELG: The Next Biotech Stock to Breakout

Another day, another new all-time high for biotech stocks. The clock-like consistency with which the hottest sector on Wall Street vaults to new heights each week is almost scary.

And yet, the biotech boom rolls on. While this may end badly at some point, no sense in fretting over the inevitable end of a trend. Simply ride it while it lasts.

The next stock bulls should set their sights on is Celgene  Corporation  (NASDAQ:CELG). Unlike many of its peers who have already launched from support or well established bases, CELG stock is just now attempting to break out of a multi-month ascending triangle.

A closer inspection of Celgene’s stock chart reveals resistance in the $125 zone. A break above this price level will complete and confirm the setup. The series of higher pivot lows that has taken root over the past two months suggests an increasing aggression by dip buyers willing to snatch up shares at higher prices. As the apex of the triangle approaches a breakout becomes increasingly likely.

Please share this article

Could 10% Dividend Yielder Crescent Point Energy Corp (NYSE:CPG) Rebound 40% ?

Crescent Point Energy Corp (NYSE:CPG) — This Canadian oil and gas producer is a standout because of its strong balance sheet and high, stable dividend yield. It is currently the largest holding in Guggenheim Canadian Energy Income ETF (NYSE:ENY).

Last week, analysts at Raymond James Financial, Inc. (NYSE:RJF) upgraded CPG stock to “outperform” from “market perform” and increased their target price to $34 from $32. They said that Crescent Point is “one of the only high-yielding energy names with a sustainable business model in a prolonged lower oil price environment.”

Despite the massive decline in crude prices, the company posted record Q4 revenues and production. And management said it could see cost savings in the 15%-20% range this year.

CPG stock has three big potential catalysts: The strong likelihood of a rebound in oil prices, a subsequent strengthening of the Canadian dollar (now at $0.78 U.S.), and it 10.3% dividend yield, which is paid monthly and should provide support for shares if oil prices do continue to fall.

Technically, even though CPG stock is in a bear market, there are signs that a bottom may be near. Buying volume has outpaced selling volume since the low at $18.38 in mid-December. CPG stock failed to hold above its 50-day moving average in the second half of 2014. But it penetrated it in February for the first time since it topped near $44 this summer.

Buy CPG stock under $21.50 with a target of $30. If this is met, investors could see a return of 40%, plus dividends.
Please share this article

Facebook Inc (NASDAQ:FB) Stock Pop and Global X Funds (NASDAQ:SOCL) Look Bullish

Shares of Facebook Inc (NASDAQ:FB) jumped 1% this morning, showing strength amid a rather lackluster day on Wall Street. With stocks mixed ahead of this afternoon’s highly anticipated Federal Reserve announcement, the pop in FB stock was easy to spot as a potential haven for hot money.
Before following the herd into FB stock, however, be aware of it faces a brick wall of resistance, heretofore impenetrable.
More on that in a moment.


But first, it’s worth noting the Facebook stock rally was accompanied by a long awaited breakout in the social media-based Global X Funds (NASDAQ:SOCL). I first mentioned the potential for a big move in the SOCL ETF last month. It certainly took its time, but the bullish action in the fund was pretty convincing this week.

Source: Stockcharts.com

Further strength in SOCL should aid Facebook’s coming breakout attempt.
As the chart below shows, FB has been locked in its range-bound prison between $81.50 and $72.50 for eight months. And it’s not like the stock pays a dividend, so don’t think investors have been getting paid to wait. 
 
Any and all previous bids at breaching overhead resistance have flopped, so bulls have their work cut out for them if the current attempt is going to succeed.

Source: Stockcharts.com

Would-be FB stock buyers seeking more confirmation that today’s rally will continue should wait until we break above the $81.50 zone before piling in.

Should the FB Breakout Come, Play It With Options

Traders looking for a cheaper alternative to buying Facebook shares could consider buying call options on the breakout. With implied volatility at the lower end of its one-year range options premiums are definitely on the cheap side these days.
Buy the Jun $77.50 calls. The current price is $6, but if you wait for a breakout (which I suggest) the price should be a bit higher.
The risk is limited to the initial debit paid, while the reward is unlimited.
Should FB finally break free of its range and embark on a new uptrend, you’ll be well-positioned to profit with these call options.
Please share this article

Whiting Petroleum Corp (NYSE: WLL)

Whiting Petroleum Corporation, an independent oil and gas company, acquires, explores, develops, and produces crude oil, natural gas liquids, and natural gas in the Rocky Mountains and Permian Basin regions of the United States. It sells oil and gas to end users, marketers, and other purchasers. As of December 31, 2014, the company’s estimated proved reserves totaled 780.3 million barrels of oil equivalent; and had interests in 4,471 net productive wells across approximately 886,700 net developed acres.
Take a look at the 1-year chart of Whiting (NYSE: WLL) below with my added notations:

WLL has formed a clear resistance at $40 (red). In addition, the stock is climbing a short-term, uptrending support level (green) over the last couple of months. These two levels combined have WLL stuck within a common chart pattern known as an ascending triangle. Eventually, the stock will have to break one of those levels.

The Tale of the Tape: WLL has an uptrending support and a $40 resistance level to watch. A long trade could be made on a breakout above $40 or on a pullback to the trendline. A break below the trendline support would be an opportunity to enter a short trade.
Please share this article

2 Biotech Stocks under $10 to Scoop up Now: Progenics Pharmaceuticals (NASDAQ: PGNX), IntelliPharmaCeutics International Inc. (NASDAQ: IPCI)

There is just something about an equity selling for under $10.00 a share that appeals to certain investors. Maybe it is the potential thrill of seeing a stock purchased at $8.00 a share soar to $25.00 a share in short order or just the fact that one can buy many more shares of a stock selling for $6.00 a share than one selling for $75.00 a share.
I like stocks under $10 simply because the vast majority come from the small cap arena which has been a focus area of my investing for over two decades and where most of my outsized gains have originated. It is this success and passion that led me to establish the Small Cap Gems portfolio last summer. I particularly like plumbing the small cap biotech and biopharma arenas to find these potential multi-baggers.
Some of the stocks that I originally profiled when they traded in the single digits over the last few months here at Investors Alley now comfortably trade in the mid-teens. These include ZIOPHARMA Oncology (NASDAQ: ZIOP) and Halozyme Therapeutics (NASDAQ: HALO). Hoping to find the same success here are two stocks selling for less than $10 a share that easily could be trading much higher in the foreseeable future. (more)

Please share this article

Oil glut going from bad to worse, EIA says supplies hit 80-year high

WTI crude (CLJ15.NYM) prices are taking another leg down, hovering at the $42 a barrel level after the U.S. Energy Information Administration reported that "U.S. crude oil inventories are at the highest level for this time of year in at least the last 80 years."

Related: EIA data for the week ending March 15, 2015

EIA reported commercial crude inventories increased by 9.6 million barrels from the previous week. Now at 458.5 million barrels. This follows a huge inventory build of 10.5 million barrels, reported late Tuesday by the American Petroleum Institute. Analysts were expecting just 3.5 million.

Jeff Mower, a director, Americas Oil News, told Yahoo Finance rising supplies are not a surprise because production remains high and refiners are in a seasonal slowdown. "A lot of refiners are down for maintenance and the crude has no place to go." The stronger U.S. dollar has also been a drag on oil prices, however Mower says that is almost irrelevant. "You need to look at the bigger picture," which is ballooning supplies. "There is this connection but it's not really a one-to-one connection considering what's going on fundamentally."

Please share this article